Benjamin Winograd

Benjamin Winograd

No open positions remaining
65 year
Health Technology
Consumer Services
Commercial Services

Profile

Benjamin Winograd worked as an Executive Director-Clinical Oncology at Bristol Myers Squibb Co. from 1990 to 1999.
He then worked as Vice President-Global Medical Affairs & Oncology at Schering-Plough Biopharma from 2004 to 2007.
From 2007 to 2020, he worked at Celgene Corp.
as Head-Clinical R&D Therapeutic Area.
Currently, he is the Chief Medical Officer at LAVA Therapeutics NV, a position he started in 2020 and will hold until 2023.
Dr. Winograd received his graduate and doctorate degrees from Technische Universität München.

Former positions of Benjamin Winograd

CompaniesPositionEnd
LAVA THERAPEUTICS Chief Tech/Sci/R&D Officer 05/02/2023
CELGENE Corporate Officer/Principal 31/12/2019
Corporate Officer/Principal 31/12/2006
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 31/12/1998
See the detail of Benjamin Winograd's experience

Training of Benjamin Winograd

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Benjamin Winograd